Exaggerated Blood Pressure Variability Superimposed on Hypertension Aggravates Cardiac Remodeling in Rats via Angiotensin II System-Mediated Chronic Inflammation

Hypertensive patients with large blood pressure variability (BPV) have aggravated end-organ damage. However, the pathogenesis remains unknown. We investigated whether exaggerated BPV aggravates hypertensive cardiac remodeling and function by activating inflammation and angiotensin II–mediated mechanisms. A model of exaggerated BPV superimposed on chronic hypertension was created by performing bilateral sinoaortic denervation (SAD) in spontaneously hypertensive rats (SHRs). SAD increased BPV to a similar extent in Wistar Kyoto rats and SHRs without significant changes in mean blood pressure. SAD aggravated left ventricular and myocyte hypertrophy and myocardial fibrosis to a greater extent and impaired left ventricular systolic function in SHRs. SAD induced monocyte chemoattractant protein-1, transforming growth factor-&bgr;, and angiotensinogen mRNA upregulations and macrophage infiltration of the heart in SHRs. The effects of SAD on cardiac remodeling and inflammation were much smaller in Wistar Kyoto rats compared with SHRs. Circulating levels of norepinephrine, the active form of renin, and inflammatory cytokines were not affected by SAD in Wistar Kyoto rats and SHRs. A subdepressor dose of candesartan abolished the SAD-induced left ventricular/myocyte hypertrophy, myocardial fibrosis, macrophage infiltration, and inductions of monocyte chemoattractant protein-1, transforming growth factor-&bgr;, and angiotensinogen and subsequently prevented systolic dysfunction in SHRs with SAD. These findings suggest that exaggerated BPV induces chronic myocardial inflammation and thereby aggravates cardiac remodeling and systolic function in hypertensive hearts. The cardiac angiotensin II system may play a role in the pathogenesis of cardiac remodeling and dysfunction induced by a combination of hypertension and exaggerated BPV.

[1]  T. Imaizumi,et al.  Inhibition of Progression and Stabilization of Plaques by Postnatal Interferon-γ Function Blocking in ApoE-Knockout Mice , 2007, Circulation research.

[2]  T. Imaizumi,et al.  Inhibition of Intrinsic Interferon-&ggr; Function Prevents Neointima Formation After Balloon Injury , 2007, Hypertension.

[3]  T. Imaizumi,et al.  Perivascular Inflammation and Hypertensive Cardiovascular Remodeling , 2006 .

[4]  T. Imaizumi,et al.  Pressure Overload–Induced Transient Oxidative Stress Mediates Perivascular Inflammation and Cardiac Fibrosis through Angiotensin II , 2006, Hypertension Research.

[5]  T. Imaizumi,et al.  Diastolic Dysfunction in Hypertensive Hearts: Roles of Perivascular Inflammation and Reactive Myocardial Fibrosis , 2005, Hypertension Research.

[6]  G. Tsivgoulis,et al.  Time Rate of Blood Pressure Variation Is Associated With Increased Common Carotid Artery Intima-Media Thickness , 2005, Hypertension.

[7]  G. Parati,et al.  Assessing the prognostic relevance of blood pressure variability: discrepant information from different indices , 2005, Journal of hypertension.

[8]  S. Kudoh,et al.  Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II , 2004, Nature Cell Biology.

[9]  A. Takeshita,et al.  Hypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation? , 2004, Hypertension.

[10]  T. Imaizumi,et al.  Pressure-Independent Effects of Angiotensin II on Hypertensive Myocardial Fibrosis , 2004, Hypertension.

[11]  C. Bulpitt,et al.  Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population , 2003, Journal of hypertension.

[12]  T. Imaizumi,et al.  Roles of Intercellular Adhesion Molecule-1 in Hypertensive Cardiac Remodeling , 2003, Hypertension.

[13]  K. Egashira.  Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1 , 2003, Hypertension.

[14]  D. Su,et al.  Effects of Long-term Treatment with Candesartan on Organ Damages in Sinoaortic Denervated Rats , 2003, Journal of cardiovascular pharmacology.

[15]  AkiraTakeshita,et al.  Transforming Growth Factor-β Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded Rats , 2002 .

[16]  Roberto Sega,et al.  Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). , 2002, Hypertension.

[17]  G Parati,et al.  Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) , 2001, Journal of hypertension.

[18]  D. Su,et al.  Arterial Remodeling in Chronic Sinoaortic-Denervated Rats , 2001, Journal of cardiovascular pharmacology.

[19]  M. Kikuya,et al.  Prognostic Significance of Blood Pressure and Heart Rate Variabilities: The Ohasama Study , 2000, Hypertension.

[20]  B. Conrad,et al.  Relationship Between Circadian Blood Pressure Patterns and Progression of Early Carotid Atherosclerosis: A 3-Year Follow-Up Study , 2000, Circulation.

[21]  A. Tessitore,et al.  Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. , 1999, Circulation.

[22]  J. Montani,et al.  Contribution of baroreceptors and chemoreceptors to ventricular hypertrophy produced by sino‐aortic denervation in rats , 1999, The Journal of physiology.

[23]  D. Ganten,et al.  Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats. , 1999, Journal of cardiovascular pharmacology.

[24]  H. Nishi,et al.  Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. , 1998, Circulation research.

[25]  A. Takeshita,et al.  Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. , 1997, Hypertension.

[26]  W. R. Taylor,et al.  Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. , 1997, Hypertension.

[27]  J. Montani,et al.  Cardiac hypertrophy and telemetered blood pressure 6 wk after baroreceptor denervation in normotensive rats. , 1996, The American journal of physiology.

[28]  R. Alexander.  Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. , 1995, Hypertension.

[29]  R. Alexander,et al.  Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. , 1994, Hypertension.

[30]  B. Berk,et al.  The angiotensin II AT1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. , 1994, Biochemical and biophysical research communications.

[31]  G Mancia,et al.  Prognostic value of 24-hour blood pressure variability , 1993, Journal of hypertension.

[32]  J. S. Janicki,et al.  Myocardial fibrosis: functional significance and regulatory factors. , 1993, Cardiovascular research.

[33]  P. Palatini,et al.  Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. , 1992, Archives of internal medicine.

[34]  F. Rengo,et al.  Differences in blood pressure profile between young and elderly hypertensive patients. , 1990, Journal of human hypertension.

[35]  J. Floras,et al.  Factors influencing blood pressure and heart rate variability in hypertensive humans. , 1988, Hypertension.

[36]  G Parati,et al.  Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. , 1987, Journal of hypertension.

[37]  A Pedotti,et al.  Blood Pressure and Heart Rate Variabilities in Normotensive and Hypertensive Human Beings , 1983, Circulation research.

[38]  M. Velasquez,et al.  Indices of sympathetic activity in the sinoaortic-denervated hypertensive rat. , 1980, The American journal of physiology.

[39]  E. Krieger,et al.  Neurogenic Hypertension in the Rat , 1964, Circulation research.

[40]  Satoshi Imaizumi,et al.  Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. , 2008, Molecular endocrinology.

[41]  草場 健.  Inhibition of intrinsic interferon-γ function prevents neointima formation after balloon injury , 2007 .

[42]  Y. Ouchi,et al.  Thrombotic Microangiopathy in Malignant Hypertension and Hemolytic Uremic Syndrome (HUS)/Thrombotic Thrombocytopenic Purpura (TTP): Can We Differentiate One from the Other? , 2005, Hypertension Research.

[43]  Beretta-Piccoli,et al.  Plasma Catecholamines and Essential Hypertension An Analytical Review , 2005 .

[44]  D. Ganten,et al.  Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. , 1999, Hypertension.

[45]  D. Goldstein,et al.  Plasma catecholamines and essential hypertension. An analytical review. , 1983, Hypertension.